CLASS III Drug recall · Reported 13 Apr 2022 · FDA Enforcement Report

23.4% Sodium Chloride Injection, 120 mEq recalled by The Ritedose

The Ritedose is recalling 23.4% Sodium Chloride Injection, 120 mEq per (4 mEq/mL) prefilled syring, distributed nationwide in the US. The recall was initiated on 1 Apr 2022 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLots: 210137-01 BUD: 05/25/2022; 220026-01 BUD: 8/12/2022; 220050-01 BUD: 08/22/2022
Quantity recalled3795 syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0745-2022
FDA event ID
89937
Recalling firm
The Ritedose, Columbia, SC
Classification
Class III
Status
Terminated
Recall initiated
1 Apr 2022
FDA classified
5 Apr 2022
Reported
13 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

1 Apr 2022Recall initiated by company
5 Apr 2022Classified by FDA+4 days
13 Apr 2022Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.

Product as listed by the FDA

23.4% Sodium Chloride Injection, 120 mEq per 30 mL (4 mEq/mL), 50 mL prefilled syring, Rx Only, RITEDOSE, 503B Outsourcing Facility, A Division of the RITEDOSE Corporation, 1 Technology Circle, Columbia, SC 29203, 1-866-994-4670, NDC: 65302-509-30, barcode N (01) 003 65302 50930 0

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Labeling: Incorrect Barcode: Product barcode incorrectly identifies the product as rocuronium bromide injection 100 mg per 10 mL instead of sodium chloride injection 23.4%, 120 mEq per 30 mL.

Which lots are affected?

Lots: 210137-01 BUD: 05/25/2022; 220026-01 BUD: 8/12/2022; 220050-01 BUD: 08/22/2022

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Ritedose

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIFormoterol Fumarate Inhalation Solution, 20mcg recalled by The RitedoseFormoterol Fumarate Inhalation SolutionThe RitedosePotency & AssayNationwide
DrugCLASS IICromolyn Sodium Oral Solution (Concentrate) 100 mg recalledThe RitedoseManufacturing (CGMP) DeviationsNationwide

Other Sodium Chloride recalls

All 133